Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Free Report) – Equities research analysts at HC Wainwright cut their Q3 2023 earnings estimates for shares of Rani Therapeutics in a research report issued to clients and investors on Monday, August 14th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of […]